Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29
Closed -$5K 1114
2021
Q4
$5K Hold
29
﹤0.01% 950
2021
Q3
$4K Hold
29
﹤0.01% 927
2021
Q2
$4K Hold
29
﹤0.01% 917
2021
Q1
$4K Hold
29
﹤0.01% 975
2020
Q4
$3K Buy
+29
New +$3.38K ﹤0.01% 978

Other funds holding NOVT

HM Payson & Co's NOVT Position: Q1 2022 in Review

HM Payson & Co sold out of Novanta (NOVT) in Q1 2022, closing a stake of 29 shares — an estimated $5K sold.

HM Payson & Co first reported a position in NOVT in Q4 2020 and held it in 5 quarters. The position peaked at $5K in Q4 2021. 231 funds tracked by Wall St. Rank hold NOVT as of Q1 2022.

  • HM Payson & Co reported no remaining Novanta position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 29 Novanta shares in Q1 2022, an estimated $5K.
  • HM Payson & Co first reported a position in Novanta in Q4 2020 and held it in 5 quarters.
  • HM Payson & Co's Novanta position peaked at $5K in Q4 2021.
  • 231 funds tracked by Wall St. Rank held Novanta as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.